Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
1.240
+0.680 (121.35%)
At close: Sep 26, 2025, 4:00 PM EDT
1.170
-0.070 (-5.65%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Applied Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Applied Therapeutics stock ranges from a low of $1.50 to a high of $8.00. The average analyst price target of $4.13 forecasts a 233.06% increase in the stock price over the next year.
Price Target: $4.13 (+233.06%)
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for Applied Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +20.97% | May 14, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +20.97% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +61.29% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +545.16% | Nov 29, 2024 |
Financial Forecast
Revenue This Year
340.00K
from 455.00K
Decreased by -25.28%
Revenue Next Year
20.51M
from 340.00K
Increased by 5,931.24%
EPS This Year
-0.58
from -0.76
EPS Next Year
-0.52
from -0.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.1M | 43.5M | |||
| Avg | 339,997 | 20.5M | |||
| Low | n/a | 8.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 130.8% | 12,685.4% | |||
| Avg | -25.3% | 5,931.2% | |||
| Low | - | 2,365.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.47 | -0.34 | |||
| Avg | -0.58 | -0.52 | |||
| Low | -0.65 | -0.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.